account...and lowering 2010-2012 non GAAP EPS by $0.85 ... could exceed $300 mn. Assuming the FDA bases the profit disgorgement on US sales in 2009, we...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Genzyme (NASDAQ:GENZ): Downgraded to Underweight at J.P. Morgan
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account